Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer. - Wikidata - wikimedia - TriplyDB

Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer.

Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer.

http://www.wikidata.org/entity/Q34403588

about

Update on the Management of Pancreatic Cancer in Older Adults.Individualized radiotherapy (iRT) concepts for locally advanced pancreatic cancer (LAPC): indications and prognostic factors.Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies.Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma.A successful case of locally advanced pancreatic cancer undergoing curative distal pancreatectomy with en bloc celiac axis resection after combination chemotherapy of nab-paclitaxel with gemcitabine.

P2860

Q36095529-472F97DD-64D5-4895-89C7-92C6CFD106F3 Q38413842-2AAB87FA-FC3E-4690-891C-F150A9A63FFF Q39390859-A5FF1712-91AC-4A7C-8585-A96525D905C7 Q40725730-8CDCA9B8-6E48-437F-8C54-99C028DA74B3 Q48098527-94F4BBAD-7F0F-43C6-A1C9-CECCC83D368A

P2860

Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer.

http://www.wikidata.org/entity/Q34403588

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Intensified Neoadjuvant Chemot ...... nresectable Pancreatic Cancer.

@ast

Intensified Neoadjuvant Chemot ...... nresectable Pancreatic Cancer.

@en

Intensified Neoadjuvant Chemot ...... nresectable Pancreatic Cancer.

@nl

type

label

Intensified Neoadjuvant Chemot ...... nresectable Pancreatic Cancer.

@ast

Intensified Neoadjuvant Chemot ...... nresectable Pancreatic Cancer.

@en

Intensified Neoadjuvant Chemot ...... nresectable Pancreatic Cancer.

@nl

prefLabel

Intensified Neoadjuvant Chemot ...... nresectable Pancreatic Cancer.

@ast

Intensified Neoadjuvant Chemot ...... nresectable Pancreatic Cancer.

@en

Intensified Neoadjuvant Chemot ...... nresectable Pancreatic Cancer.

@nl

P1433

Q34403588-CB61B49A-2A96-4D6F-A2A2-1006804D8105

P1476

Q34403588-D753D6B0-7034-4224-9B06-A271D396A195

P2093

Q34403588-1E1F6953-3ADC-4707-AC5B-D9BC5E4410E9

Q34403588-7C6DE442-55E5-4B29-9D03-9530A564AE46

Q34403588-A9211A6B-50F4-4514-AF92-B669CDC296DC

Q34403588-D20B64BE-6110-4CDE-BCA8-5789EC4842D8

Q34403588-F426FFAF-C0C5-491F-B005-86C5E79CB0B4

Q34403588-FA65BB35-4282-406D-B290-23B7BF38095D

P2860

Q34403588-4AC9B563-91E0-41DD-BC5D-473C42FD0CD6

Q34403588-504DFB25-1568-425E-B12E-7D700C7E67C8

Q34403588-A72A7218-7E2E-4204-9D6D-94F7438B8412

Q34403588-C5F6BEF4-5118-4A79-A03E-8283BABE6905

Q34403588-E186CAFB-7555-4C10-AC6F-2796793F292A

Q34403588-E41E660A-C7CA-4136-88BA-6DCE01CAE7E5

Q34403588-E65276E5-108C-49B3-89E7-A82CE6907956

Q34403588-FC98224F-C9F2-480D-A291-0AD7DF68FDBA

P304

Q34403588-1284B6CE-A463-439B-88B8-BCF8546244DB

P31

Q34403588-257E1C37-FE06-4E19-BDB0-0B762600EE9E

Q34403588-5d94c2cc-a7db-4b9f-a2b0-33dfcf256efd

P356

Q34403588-F574C691-F12E-4573-92BC-D2DC73FCCDA1

P433

Q34403588-AFFA3DA6-773B-4CDF-A5F1-9691B2D25C0C

P478

Q34403588-3755B6ED-839D-4216-9C8A-102040B140DA

P577

Q34403588-DFD18707-A0E1-474F-A2B0-2241FC46B26B

P5875

Q34403588-865D0A1F-E70D-48CF-87B2-DC12FB62A564

P698

Q34403588-92DD4699-5B96-48CA-8620-0F8BA09BE90D

P921

Q34403588-419825FA-0464-41C0-83CC-C8EAE60F8F8D

Q34403588-B414960E-F4B6-421B-B91A-94717AA027A1

P932

Q34403588-81CAE493-3937-41D9-B8AB-FF27BB2B8C9D

P356

P1433

Case reports in oncology

P1476

Intensified Neoadjuvant Chemot ...... nresectable Pancreatic Cancer.

@en

P2093

Christina Bluemel

http://www.w3.org/2001/XMLSchema#string

Ingo Hartlapp

http://www.w3.org/2001/XMLSchema#string

Ken Herrmann

http://www.w3.org/2001/XMLSchema#string

Markus Kapp

http://www.w3.org/2001/XMLSchema#string

Ulrich Steger

http://www.w3.org/2001/XMLSchema#string

Volker Kunzmann

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer

Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy.

Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies.

Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.

Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

P304

648-655

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000367966

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268791854

http://www.w3.org/2001/XMLSchema#string

P698

25408659

http://www.w3.org/2001/XMLSchema#string

P921

P932

4209279

http://www.w3.org/2001/XMLSchema#string